Funding opportunities
Gilde Healthcare Partners, the Netherlands, has announced the closing of its €150 million venture fund, Gilde Healthcare II (GHC II). The Utrecht-based firm claims the new fund, its second healthcare fund, is one of the largest raised to invest in European healthcare opportunities.
GHC II was backed by current investors in Gilde Healthcare Funds, who have been joined by a small group of new investors. The original target for GHCII was €125 million.
GHCII will invest in companies developing therapeutics, diagnostics, medical devices and enabling technologies, at all stages of a development from seed to pre-IPO rounds. Investments will range from €1 million up to €15 million, and it is planned to make more than 15 venture investments from GHCII.
"We believe this successful fund raising reflects our high quality portfolio, which contains many of the most successful emerging healthcare companies in Europe,” said Pieter van der Meer, General Partner.
“Our investment approach, which is not biased towards any particular country, means that we can invest in the best healthcare opportunities being created across the whole of Europe.”
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
